Gene · 388
Papers2,874
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,874
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Folic acid-targeted redox responsive polylactic acid-based nanoparticles co-delivering pirarubicin and salinomycin suppress breast cancer tumor growth in vivo. | Nanoscale | 2024 | 39420738 | PubTator, text mining | PubMed |
| AAMP and MTSS1 Are Novel Negative Regulators of Endothelial Barrier Function Identified in a Proteomics Screen. | Cells | 2024 | 39404373 | PubTator, text mining | PubMed |
| Analysis of chromatin accessibility in peripheral blood mononuclear cells from patients with early-stage breast cancer. | Front Pharmacol | 2024 | 39376611 | PubTator, text mining | PubMed |
| Downregulation of RhoB Inhibits Cervical Cancer Progression and Enhances Cisplatin Sensitivity. | Genes (Basel) | 2024 | 39336777 | PubTator, text mining | PubMed |
| Retraction to "MiR-223-3p regulates cell viability, migration, invasion, and apoptosis of non-small cell lung cancer cells by targeting RHOB". | Open Life Sci | 2024 | 39220592 | PubTator, text mining | PubMed |
| Enhancing Cell Aggregation and Migration via Double-Click Cross-Linking with Azide-Modified Hyaluronic Acid. | Bioconjug Chem | 2024 | 39213494 | PubTator, text mining | PubMed |
| Quantitative proteomics and immunohistochemistry uncover NT5DC2 as a diagnostic biomarker for papillary urothelial carcinoma. | Heliyon | 2024 | 39165948 | PubTator, text mining | PubMed |
| Anti-tumor effects of the eIF4A inhibitor didesmethylrocaglamide and its derivatives in human and canine osteosarcomas. | Sci Rep | 2024 | 39164287 | PubTator, text mining | PubMed |
| A Comparative Study Based on Petrophysical and Cluster Analysis Approach for Identification of Rock Types in Heterogeneous Sandstone Reservoirs. | ACS Omega | 2024 | 39130539 | PubTator, text mining | PubMed |
| The RhoB p.S73F mutation leads to cerebral palsy through dysregulation of lipid homeostasis. | EMBO Mol Med | 2024 | 39080495 | PubTator, text mining | PubMed |
| The Use of Effective Core Potentials with Multiconfiguration Pair-Density Functional Theory. | J Phys Chem A | 2024 | 39052857 | PubTator, text mining | PubMed |
| MiR-21-5p knockdown inhibits epithelial to mesenchymal transition in A549 lung adenocarcinoma cells by upregulating RhoB. | Mol Biol Rep | 2024 | 39042337 | PubTator, text mining | PubMed |
| Endometrial scratching in unexplained repeated implantation failure causes two competing forces, angiogenesis and anti-angiogenesis: An RCT study. | Int J Reprod Biomed | 2024 | 39035633 | PubTator, text mining | PubMed |
| RhoB plays a central role in hyperosmolarity-induced cell shrinkage in renal cells. | J Cell Physiol | 2024 | 38946197 | PubTator, text mining | PubMed |
| Identification of angiogenesis-related genes and molecular subtypes for psoriasis based on random forest algorithm. | Clin Exp Immunol | 2024 | 38938103 | PubTator, text mining | PubMed |
| Retraction Notice to: The Pseudogene DUXAP8 Promotes Non-small-cell Lung Cancer Cell Proliferation and Invasion by Epigenetically Silencing EGR1 and RHOB. | Mol Ther | 2024 | 38857596 | PubTator, text mining | PubMed |
| MechanoBase: a comprehensive database for the mechanics of tissues and cells. | Database (Oxford) | 2024 | 38805752 | PubTator, text mining | PubMed |
| PITPNA-AS1 Inhibits Cell Proliferation and Migration in Ovarian Cancer by Regulating the MIR-223-3p/RHOB Axis. | Rev Invest Clin | 2024 | 38753591 | PubTator, text mining | PubMed |
| A novel defined programmed cell death related gene signature for predicting the prognosis of serous ovarian cancer. | J Ovarian Res | 2024 | 38685095 | PubTator, text mining | PubMed |
| Transcriptomics Studies Reveal Functions of Transglutaminase 2 in Breast Cancer Cells Using Membrane Permeable and Impermeable Inhibitors. | J Mol Biol | 2024 | 38604527 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/388/papers?page=5